These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15495049)

  • 1. Antitumour antibiotic containing regimens for metastatic breast cancer.
    Lord S; Ghersi D; Gattellari M; Wortley S; Wilcken N; Simes J
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD003367. PubMed ID: 15495049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum containing regimens for metastatic breast cancer.
    Carrick S; Ghersi D; Wilcken N; Simes J
    Cochrane Database Syst Rev; 2004; (3):CD003374. PubMed ID: 15266482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single agent versus combination chemotherapy for metastatic breast cancer.
    Carrick S; Parker S; Wilcken N; Ghersi D; Marzo M; Simes J
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003372. PubMed ID: 15846660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum-containing regimens for metastatic breast cancer.
    Egger SJ; Willson ML; Morgan J; Walker HS; Carrick S; Ghersi D; Wilcken N
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003374. PubMed ID: 28643430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum containing regimens for metastatic breast cancer.
    Carrick S; Ghersi D; Wilcken N; Simes J
    Cochrane Database Syst Rev; 2004; (2):CD003374. PubMed ID: 15106201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of drug/s to a chemotherapy regimen for metastatic breast cancer.
    Jones D; Ghersi D; Wilcken N
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003368. PubMed ID: 16856005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxane containing regimens for metastatic breast cancer.
    Ghersi D; Wilcken N; Simes J; Donoghue E
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003366. PubMed ID: 15846659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taxane containing regimens for metastatic breast cancer.
    Ghersi D; Wilcken N; Simes J; Donoghue E
    Cochrane Database Syst Rev; 2003; (3):CD003366. PubMed ID: 12917963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum-containing regimens for triple-negative metastatic breast cancer.
    Egger SJ; Chan MMK; Luo Q; Wilcken N
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013750. PubMed ID: 33084020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxane-containing regimens for metastatic breast cancer.
    Ghersi D; Willson ML; Chan MM; Simes J; Donoghue E; Wilcken N
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD003366. PubMed ID: 26058962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of drug/s to a chemotherapy regimen for metastatic breast cancer.
    Butters DJ; Ghersi D; Wilcken N; Kirk SJ; Mallon PT
    Cochrane Database Syst Rev; 2010 Nov; 2010(11):CD003368. PubMed ID: 21069675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trastuzumab-containing regimens for metastatic breast cancer.
    Balduzzi S; Mantarro S; Guarneri V; Tagliabue L; Pistotti V; Moja L; D'Amico R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006242. PubMed ID: 24919460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxanes for adjuvant treatment of early breast cancer.
    Ferguson T; Wilcken N; Vagg R; Ghersi D; Nowak AK
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004421. PubMed ID: 17943815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination versus sequential single agent chemotherapy for metastatic breast cancer.
    Dear RF; McGeechan K; Jenkins MC; Barratt A; Tattersall MH; Wilcken N
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD008792. PubMed ID: 24347031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single agent versus combination chemotherapy for metastatic breast cancer.
    Carrick S; Parker S; Thornton CE; Ghersi D; Simes J; Wilcken N
    Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD003372. PubMed ID: 19370586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
    Gibson LJ; Dawson C; Lawrence DH; Bliss JM
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003370. PubMed ID: 17253488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline-containing regimens for treatment of follicular lymphoma in adults.
    Itchaki G; Gafter-Gvili A; Lahav M; Vidal L; Raanani P; Shpilberg O; Paul M
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD008909. PubMed ID: 23832787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.
    Wilcken N; Hornbuckle J; Ghersi D
    Cochrane Database Syst Rev; 2003; 2003(2):CD002747. PubMed ID: 12804433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of taxane-containing regimens for metastatic breast cancer.
    Ghersi D; Wilcken N; Simes RJ
    Br J Cancer; 2005 Aug; 93(3):293-301. PubMed ID: 16052223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
    van Dalen EC; Raphaël MF; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006647. PubMed ID: 19160293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.